Children's Cancer Group, China

This study compares two different ways of giving the chemotherapy drug methotrexate to children and teens newly diagnosed with T-cell lymphoblastic lymphoma, a rare cancer. The goal is to see which approach leads to better event-free survival. About 200 participants will be rando…

This study tests a new treatment for children, teens, and young adults (ages 2 to 34) with newly diagnosed classical Hodgkin lymphoma. The drug brentuximab vedotin replaces two older drugs in a standard chemo regimen, aiming to shrink tumors faster and reduce the need for radiati…